Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis

Giuseppe Guaiana*, Corrado Barbui, Deborah M. Caldwell, Simon J.C. Davies, Toshi A. Furukawa, Hissei Imai, Markus Koesters, Aran Tajika, Irene Bighelli, Alessandro Pompoli, Andrea Cipriani

*Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

5 Citations (Scopus)
272 Downloads (Pure)

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To compare individual active drugs (antidepressants, benzodiazepines and azapirones) and placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or without agoraphobia. To rank treatments for panic disorder (antidepressants, benzodiazepines, azapirones and placebo) according to their effectiveness and acceptability.

Original languageEnglish
Article numberCD012729
Number of pages21
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number7
DOIs
Publication statusPublished - 31 Jul 2017

Fingerprint Dive into the research topics of 'Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis'. Together they form a unique fingerprint.

Cite this